Corinne Le Goff
Chief Commercial OfficerViatris
PharmaceuticalsView Profile →Senior Vice President, Global Immunology Commercial Business Unit · Regeneron Pharmaceuticals
Brook Jennings is senior vice president of the global immunology commercial business unit at Regeneron Pharmaceuticals. He joined in 2015 and has led immunology marketing and U.S. dermatology sales and marketing, following pharmaceutical leadership at LEO Pharma, Novartis and Johnson & Johnson.
Last reviewed: Oct 21, 2026
Senior Vice President, Global Immunology Commercial Business Unit Regeneron Pharmaceuticals
Last Reviewed: October 21, 2026
Brook Jennings is senior vice president of the global immunology commercial business unit at Regeneron Pharmaceuticals. He joined in 2015 and has led immunology marketing and U.S. dermatology sales and marketing, following pharmaceutical leadership at LEO Pharma, Novartis and Johnson & Johnson.
Jennings developed his pharmaceutical career through sales and marketing roles at Johnson & Johnson and global allergy and immunology responsibilities at Novartis. He later led the psoriasis franchise at LEO Pharma, participating in its U.S. and global leadership teams and overseeing sales, marketing and product transitions.
He joined Regeneron in 2015. His responsibilities have included guiding immunology marketing through the global launches of Dupixent for atopic dermatitis, asthma and chronic rhinosinusitis with nasal polyps. Beginning in 2020, he led U.S. dermatology sales and marketing through additional indications.
He now serves as senior vice president of the Global Immunology Commercial Business Unit. His career connects disease-area knowledge with the sales and marketing organization supporting new and established uses of an immunology medicine. These are commercial launch responsibilities within a collaborative development and commercialization program, rather than a claim that he personally discovered the medicine.
Jennings earned a BA in biology from Kenyon College.